Programmed cell death and cancer

Annals of the Academy of Medicine Singapore

Volumn 25, Issue 2, 1996, Pages 259-264

  Hwang, P L ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Apoptosis; Gene; Malignancy; Mutation; Self destruction

Indexed keywords

APOPTOSIS; GENETICS; HUMAN; NEOPLASM; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

APOPTOSIS; HUMANS; NEOPLASMS;

EID: 0030098220     PISSN: 03044602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. Kerr J F R, Harmon B V. Definition and incidence of apoptosis: a historical perspective. In: Tomei L D, Cope F O, editors. Apoptosis: The Molecular Basis of Cell Death New York: Cold Spring Harbor Laboratory Press, 1991:5-29.
2. Lavin M, Watters D, editors Programmed Cell Death: The Cellular and Molecular Biology of Apoptosis. Switzerland: Harwood Academic Publishers, 1993.
3. Tomei L D, Cope F O, editors. Apoptosis II: The Molecular Basis of Apoptosis in Disease. New York: Cold Spring Harbor Laboratory Press, 1994.
4. Collins M K L, Rivas A L. The control of apoptosis in mammalian cells. Trends Biochem Sci 1993; 18 307-9
5. Schwartzman R A, Cidlowski J A. Apoptosis: The biochemistry and molecular biology of programmed cell death. Endocr Rev 1993, 14:133-51.
6. Driscoll M. Molecular genetics of cell death in the nematode Caenorhabditis elegans. J Neurobiol 1992; 23:1327-51.
7. Arends M J, Wyllie A H. Apoptosis: mechanisms and role in pathology. Int Rev Exp Pathol 1991; 32:223-56.
8. Carson D A, Ribeiro J M Apoptosis and disease Lancet 1993; 341:1251-4.
9. Kerr J F R, Winterford C M, Harmon B V. Apoptosis - Its significance in cancer and cancer therapy. Cancer 1994; 73:2013-26.
10. Schmandt R, Mills G B. Genomic components of carcinogenesis Clin Chem 1993, 39:2375-85
11. Tsujimoto Y, Cossman J, Jaffe E, Croce C Involvement of the bcl-2 gene in human follicular lymphoma. Science 1985; 228:1440-3.
12. Vaux D, Cory S, Adams J. Bcl-2 gene promotes haemopoiehc cell survival and cooperates with c-myc to immortalise pre-B cells. Nature 1988, 335:440-2.
13. Reed J C. Bcl-2 and the regulation of programmed cell death. J Cell Biol 1994; 124:1-6.
14. Hockenbery D M, Oltavi Z N, Yin X M, Milliman C L, Korsmeyer S J. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 1993; 75:241-51.
15. Hengartner M O, Horvitz H R. C elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2. Cell 1994; 76:665-76
16. Vaux D L, Weissman I L, Kim S K. Prevention of programmed cell death in Caenorhabditis elegans by human bcl-2. Science 1992; 258:1955-7.
17. Cleary M L, Smith S D, Sklar J. Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation. Cell 1986; 47:19-28.
18. Henderson S, Huen D, Rowe M, Dawson C, Johnson G, Rickinson A. Epstein-Barr virus-coded BHRF1 protein, a viral homologue of bcl-2 protects human B cells from programmed cell death. Proc Natl Acad Sci USA 1993; 90:8479-83.
19. McDonnel T J, Troncoso P, Brisbay S M, Logothetis C, Chung L W K, Hsieh J T, et al. Expression of the proto oncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer Cancer Res 1992; 52:6940-4.
20. Yunis J J, Mayer M G, Arensen M A, Aeppli D P, Oken M M, Frizzera G. Bcl-2 and other genomic alterations in the prognosis of large-cell lymphomas. N Engl J Med 1989; 320:1047-54.
21. Campos L, Roualult J P, Sabido O, Oriol P, Roubi N, Vasselon C, et al. High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy. Blood 1993; 18:3091-6.
22. McDonnel T J, Korsmeyer S J. Progression from lymphoid hyperplasia to high grade lymphoma in mice transgenic for the t(14;18). Nature 1991; 349:254-6.
23. Levine A J, Momand J, Finlay C A. The p53 tumour suppressor gene. Nature 1991; 351:453-6.
24. Soussi T, Legros Y, Rubin R, Ory K, Schlichtholz B Multifactorial analysis of p53 alteration in human cancer: a review. Int J Cancer 1994; 57:1-9.
25. Levine A J, Perry M E, Chang A, Silver A, Dittmer D, Wu M, et al. The role of the p53 tumour-suppressor gene in tumorigenesis. Br J Cancer 1994; 69:409-16.
26. Malkin D, Li F P, Strong L C, Fraumeni J F, Nelson C E, Kim D, et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 1990; 250:1233-8.
27. Donehower L A, Harvey M, Slagle B L, McArthur M J, Montgomery C A, Butel J S, et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 1992; 356:215-21
28. Lane D P. p53, guardian of the genome. Nature 1992; 358:15-6.
29. Yonish-Rouach E, Grunwald D, Wilder S, Kimchi A, May E, Lawrence J J, et al. p53-mediated cell death: relationship to cell cycle control. Mol Cell Biol 1993; 13:1415-23.
30. Shaw P, Bovey R, Tardy S, Sahli R, Sordat B, Costa J. Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. Proc Natl Acad Sci USA 1992; 89:4495-9
31. Lowe S W, Schmitt E M, Smith S W, Osborne B A, Jacks T. p53 is required for radiation induced apoptosis in mouse thymocytes. Nature 1993;362:847-9.
32. Shi Y, Glynn J M, Guilbert L J, Cotter T G, Bissonnette R P, Green D R. Role of c-myc in activation-induced apoptotic cell death in T cell hybridomas. Science 1992; 257:211-4.
33. Evans G I, Wyllie A H, Gilbert C S, Littlewood T D, Land H, Brooks M, et al. Induction of apoptosis in fibroblasts by c-myc protein. Cell 1992; 69.119-28.
34. Quarmby V, Beekman W, Wilson E, French F. Androgen regulation of c-myc messenger ribonucleic acid levels in rat ventral prostate. Mol Endocrinol 1987; 1:865-74.
35. Trauth B C, Klas C, Peters A M J, Matzku S, Moller P, Falk W, et al. Monoclonal antibody mediated tumour regression by induction of apoptosis. Science 1989; 245:301-5.
36. Yonehara S, Ishii A, Yonehara M. A cell killing monoclonal antibody (anti Fas) to a cell surface antigen co-downregulated with the receptor of tumour necrosis factor J Exp Med 1989; 169:1747-56.
37. Suda T, Nagata S. Purification and characterization of the fas-ligand that induces apoptosis. J Exp Med 1994; 179:873-9.
38. Suda T, Takahasi T, Golstein P, Nagata S. Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factor family. Cell 1993; 75:1169-78.
39. Watanabe-Fukunaga R, Brannan C I, Copeland N G, Jenkins N A, Nagata S Lymphoproliferation disorder in mice explained by defects in fas antigen that mediates apoptosis. Nature 1992; 356:314-7.
40. Takahashi T, Tanaka M, Brannan C I, Jenkins N A, Copeland N G, Suda T, et al. Generalised lymphoproliferative disease in mice caused by a point mutation in the fas ligand. Cell 1994; 76:969-76.
41. Miura M, Zhu H, Rotello R, Hartweig E A, Yuan J. Induction of apoptosis in fibroblasts by IL-1β converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell 1993; 75:653-60.
42. Hickman J A. Apoptosis induced by anticancer drugs. Cancer Metastasis Rev 1992; 11 121-39.
43. Stephens L C, Ang K K, Schultheiss T E, Milas L, Meyn R E. Apoptosis in irradiated murine tumors. Radiat Res 1991; 127:308-16.
44. Cotter T G, Glynn J M, Echeverri F, Green D R. The induction of apoptosis by chemotherapeutic agents occur in all phases of the cell cycle Anticancer Res 1992; 12:773-80.
45. Tenniswood M P, Guenette R S, Lakin J, Mooibroek M, Wong P, Welsh J E. Active cell death in hormone-dependent tissues. Cancer Metastasis Rev 1992; 11:197-220.
46. Lowe S W, Ruley H E, Jacks T, Housman D E. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 1993; 74:957-67.